BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20062074)

  • 1. A novel XPF -357A>C polymorphism predicts risk and recurrence of bladder cancer.
    Wang M; Wang M; Yuan L; Wu D; Zhang Z; Yin C; Fu G; Wei Q; Zhang Z
    Oncogene; 2010 Apr; 29(13):1920-8. PubMed ID: 20062074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel functional polymorphism C1797G in the MDM2 promoter is associated with risk of bladder cancer in a Chinese population.
    Wang M; Zhang Z; Zhu H; Fu G; Wang S; Wu D; Zhou J; Wei Q; Zhang Z
    Clin Cancer Res; 2008 Jun; 14(11):3633-40. PubMed ID: 18519798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Xeroderma pigmentosum complementation group F polymorphisms on gastric cancer risk and associations with H.pylori infection.
    Zhang JS; Zhang C; Yan XY; Yuan ZF; Duan ZY; Gao H
    Asian Pac J Cancer Prev; 2013; 14(3):1847-50. PubMed ID: 23679285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERCC1 gene +262A/C polymorphism associated with risk of gastric cardiac adenocarcinoma in nonsmokers.
    Zhou RM; Niu CX; Wang N; Chen ZF; Lei SE; Li Y
    Arch Med Res; 2012 Jan; 43(1):67-74. PubMed ID: 22374244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.
    Gu J; Zhao H; Dinney CP; Zhu Y; Leibovici D; Bermejo CE; Grossman HB; Wu X
    Clin Cancer Res; 2005 Feb; 11(4):1408-15. PubMed ID: 15746040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in excision repair cross-complementing group 4 (ERCC4) and susceptibility to primary lung cancer in a Chinese Han population.
    Shao M; Ma H; Wang Y; Xu L; Yuan J; Wang Y; Hu Z; Yang L; Wang F; Liu H; Qian J; Xun P; Chen W; Yuan W; Jing G; Chen F; Jin L; Wei Q; Wu T; Shen H; Huang W; Lu D
    Lung Cancer; 2008 Jun; 60(3):332-9. PubMed ID: 18068852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Analysis of SNPs in the ERCC5 Promoter in Advanced Colorectal Cancer Patients Treated With Oxaliplatin-Based Chemotherapy.
    Chen J; Luo X; Xie G; Chen K; Jiang H; Pan F; Li J; Ruan Z; Pang X; Liang H
    Medicine (Baltimore); 2016 May; 95(19):e3652. PubMed ID: 27175691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XPF-673C>T polymorphism effect on the susceptibility to esophageal cancer in Chinese population.
    Liu Y; Cao L; Chang J; Lin J; He B; Rao J; Zhang Z; Zhang X
    PLoS One; 2014; 9(4):e94136. PubMed ID: 24709955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer.
    Wang M; Wang M; Cheng G; Zhang Z; Fu G; Zhang Z
    Mutat Res; 2009 Feb; 661(1-2):85-92. PubMed ID: 19070628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel functional TagSNP Rs7560488 in the DNMT3A1 promoter is associated with susceptibility to gastric cancer by modulating promoter activity.
    Wu H; Zhang K; Gong P; Qiao F; Wang L; Cui H; Sui X; Gao J; Fan H
    PLoS One; 2014; 9(3):e92911. PubMed ID: 24667323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of DNA repair gene XPF enhances resistance to hydroxycamptothecin in bladder cancer.
    Li J; Zhang J; Liu Y; Ye G
    Med Sci Monit; 2012 Apr; 18(4):BR156-62. PubMed ID: 22460090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population.
    Bănescu C; Iancu M; Trifa AP; Dobreanu M; Moldovan VG; Duicu C; Tripon F; Crauciuc A; Skypnyk C; Bogliș A; Lazar E
    Tumour Biol; 2016 Jul; 37(7):9357-66. PubMed ID: 26779634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between XPF polymorphisms and cancer risk: a meta-analysis.
    Shi TY; He J; Qiu LX; Zhu ML; Wang MY; Zhou XY; Han J; Yu H; Zang RY; Wei Q
    PLoS One; 2012; 7(7):e38606. PubMed ID: 22768293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of XPF Levels and Genetic Polymorphism with Susceptibility to Ischemic Stroke.
    Ma Y; Deng XD; Feng Y; Zhang W; Wang SX; Liu Y; Liu H
    J Mol Neurosci; 2016 May; 59(1):168-76. PubMed ID: 26888738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nonsense mutation in the Xeroderma pigmentosum complementation group F (XPF) gene is associated with gastric carcinogenesis.
    Wei ZH; Guo WH; Wu J; Suo WH; Fu GH
    Gene; 2014 Mar; 537(2):238-44. PubMed ID: 24412486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between ERCC1 and XPF polymorphisms and risk of colorectal cancer.
    Yang H; Li G; Li WF
    Genet Mol Res; 2015 Jan; 14(1):700-5. PubMed ID: 25730007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A polymorphism (rs2295080) in mTOR promoter region and its association with gastric cancer in a Chinese population.
    Xu M; Tao G; Kang M; Gao Y; Zhu H; Gong W; Wang M; Wu D; Zhang Z; Zhao Q
    PLoS One; 2013; 8(3):e60080. PubMed ID: 23555892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of nucleotide-excision repair genes may contribute to sperm DNA fragmentation and male infertility.
    Gu A; Ji G; Zhou Y; Long Y; Shi X; Fu G; Wang S; Song L; Wang X
    Reprod Biomed Online; 2010 Nov; 21(5):602-9. PubMed ID: 20864414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of polymorphisms in nucleotide excision repair genes on glioma risk in a Chinese population.
    Wang XF; Liu S; Shao ZK
    Gene; 2013 Oct; 529(2):317-20. PubMed ID: 23911298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of TP53 are markers of bladder cancer vulnerability and prognosis.
    Lin HY; Yang MC; Huang CH; Wu WJ; Yu TJ; Lung FW
    Urol Oncol; 2013 Oct; 31(7):1231-41. PubMed ID: 22178231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.